Intracochlear infusion of buthionine sulfoximine potentiates carboplatin ototoxicity in the chinchilla

Hearing Research

Volumn 128, Issue 1-2, 1999, Pages 125-134

  Hu, Bo Hua ^a   McFadden, Sandra L ^a   Salvi, Richard J ^a   Henderson, Donald ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antioxidant; Chemotherapeutic drug; Cochlea; Hair cell; Hearing loss; Platinum

Indexed keywords

BUTHIONINE SULFOXIMINE; CARBOPLATIN; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CHINCHILLA; COCHLEA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DOSE RESPONSE; DRUG INFUSION; DRUG POTENTIATION; ELECTROCOCHLEOGRAPHY; EVOKED AUDITORY RESPONSE; HAIR CELL; INFERIOR COLLICULUS; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OSMOTIC PUMP; OTOTOXICITY; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BUTHIONINE SULFOXIMINE; CARBOPLATIN; CELL SURVIVAL; CHINCHILLA; COCHLEA; DRUG SYNERGISM; EVOKED POTENTIALS; HAIR CELLS, INNER; INFERIOR COLLICULUS; INFUSION PUMPS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; REFERENCE VALUES;

EID: 0009637678     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(98)00210-X     Document Type: Article

References (55)

1. Ahn H., Lee E., Kim K., Lee C. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. J. Urol. 151:1994;263-267.
2. Arrick B.A., Nathan C.F. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res. 44:1984;4224-4232.
3. Babu E., Gopalakrishnan V.K., Sriganth I.N., Gopalakrishnan R., Sakthisekaran D. Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol. Cell. Biochem. 144:1995;7-11.
4. Bonomi P. Carboplatin in non-small cell lung cancer: review of the Eastern Cooperative Oncology Group trial and comparison with other carboplatin trials. Semin. Oncol. 18:1991;2-7.
5. Brown J.N., Miller J.M., Altschuler R.A., Nuttall A.L. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear. Res. 70:1993;167-172.
6. Burkard R., Trautwein P., Salvi R. The effects of click level, click rate and level of background masking noise on the inferior colliculus potential (ICP) in the normal and carboplatin-treated chinchilla. J. Acoust. Soc. Am. 102:1997;3620-3627.
7. Canetta R., Rozencweig M., Carter S.K. Carboplatin: the clinical spectrum to date. Cancer Treat. Rev. 12 (Suppl. A):1985;125-136.
8. de Graeff A., Slebos R.J., Rodenhuis S. Resistance to cisplatin and analogues: mechanisms and potential clinical implications. Cancer Chemother. Pharmacol. 22:1988;325-332.
9. Eastman A. Glutathione-mediated activation of anticancer platinum(IV) complexes. Biochem. Pharmacol. 36:1987;4177-4178.
10. Ferguson P.J. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review. J. Otolaryngol. 24:1995;242-252.
11. Freilich R.J., Kraus D.H., Budnick A.S., Bayer L.A., Finlay J.L. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med. Pediatr. Oncol. 26:1996;95-100.
12. Hoffman D.W., Whitworth C.A., Jones-King K.L., Rybak L.P. Potentiation of ototoxicity by glutathione depletion. Ann. Otol. Rhinol. Laryngol. 97:1988;36-41.
13. Hofstetter P., Ding D., Powers N., Salvi R.J. Quantitative relationship between carboplatin dose, inner and outer hair cell loss and reduction in distortion product otoacoustic emission amplitude chinchillas. Hear. Res. 112:1997;199-215.
14. Hofstetter P., Ding D., Salvi R.J. Magnitude and pattern of inner and outer hair cell loss in chinchilla as a function of carboplatin dose. Audiology. 36:1997;301-311.
15. Hu B.H., Zheng X.Y., McFadden S.L., Kopke R.D., Henderson D. R-phenylisopropyladenosine attenuates noise-induced hearing loss in the chinchilla. Hear. Res. 113:1997;198-206.
16. Jock B.M., Hamernik R.P., Aldrich L.G., Ahroon W.A., Petriello K.-L., Johnson A.R. Evoked-potential thresholds and cubic distortion product otoacoustic emissions in the chinchilla following carboplatin treatment and noise exposure. Hear. Res. 96:1996;179-190.
17. Kera Y., Ohbora Y., Komura S. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication. Alcohol. 24:1989;519-524.
18. Kisara S., Furusawa S., Takayanagi Y., Sasaki K. Effect of glutathione depletion by buthionine sulfoximine on doxorubicin toxicity in mice. Res. Commun. Mol. Pathol. Pharmacol. 89:1995;401-410.
19. Lai G.M., Ozols R.F., Young R.C., Hamilton T.C. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J. Natl. Cancer Inst. 81:1989;535-539.
20. Lazenby C.M., Lee S.J., Harpur E.S., Gescher A. Glutathione depletion in the guinea pig and its effect on the acute cochlear toxicity of ethacrynic acid. Biochem. Pharmacol. 37:1988;3743-3747.
21. Lee F.Y., Allalunis-Turner M.J., Siemann D.W. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine. Br. J. Cancer. 56:1987;33-38.
22. Lee K.S., Kim H.K., Moon H.S., Hong Y.S., Kang J.H., Kim D.J., Park J.G. Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines. Korean J. Intern. Med. 7:1992;111-117.
23. Luthen R.E., Neuschwander-Tetri B.A., Niederau C., Ferrell L.D., Grendell J.H. The effect of L-buthionine-[S,R]-sulfoximine on the pancreas in mice. A model of weakening glutathione-based defense mechanisms. Int. J. Pancreatol. 16:1994;31-36.
24. Macdonald M.R., Harrison R.V., Wake M., Bliss B., Macdonald R.E. Ototoxicity of carboplatin: comparing animal and clinical models at the hospital for sick children. J. Otolaryngol. 23:1994;151-159.
25. McFadden S.L., Kasper C., Ostrowski J., Ding D., Salvi R.J. Effects of inner hair cell loss on inferior colliculus evoked potential thresholds, amplitudes and forward masking functions in chinchillas. Hear. Res. 120:1998;121-132.
26. McGinness J.E., Proctor P.H., Demopoulos H.B., Hokanson J.A., Kirkpatrick D.S. Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase). Physiol. Chem. Phys. 10:1978;267-277.
27. McKeage M.J. Comparative adverse effect profiles of platinum drugs. Drug Saf. 13:1995;228-244.
28. Meijer C., Mulder N.H., Hospers G.A., Uges D.R., de Vries E.G. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br. J. Cancer. 62:1990;72-77.
29. Meijer C., Mulder N.H., Timmer Bosscha H., Sluiter W.J., Meersma G.J., de Vries E.G. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res. 52:1992;6885-6889.
30. Mellish K.J., Kelland L.R., Harrap K.R. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br. J. Cancer. 68:1993;240-250.
31. Mistry P., Kelland L.R., Abel G., Sidhar S., Harrap K.R. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br. J. Cancer. 64:1991;215-220.
32. Mistry P., Loh S.Y., Kelland L.R., Harrap K.R. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Int. J. Cancer. 55:1993;848-856.
33. Mitchell J.B., Cook J.A., DeGraff W., Glatstein E., Russo A. Glutathione modulation in cancer treatment: will it work? Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1289-1295.
34. Mizui T., Kinouchi H., Chan P.H. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am. J. Physiol. 262:1992;H313-H317.
35. Morales C.F., Anzueto A., Andrade F., Brassard J., Levine S.M., Maxwell L.C., Lawrence R.A., Jenkinson S.G. Buthionine sulfoximine treatment impairs rat diaphragm function. Am. J. Respir. Crit. Care Med. 149:1994;915-919.
36. Pileblad E., Magnusson T. Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathione. J. Neurochem. 53:1989;1878-1882.
37. Ravi R., Somani S.M., Rybak L.P. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76:1995;386-394.
38. Ruckdeschel J.C. The future role of carboplatin. Semin. Oncol. 21:1994;114-118.
39. Russo A., Carmichael J., Friedman N., DeGraff W., Tochner Z., Glatstein E., Mitchell J.B. The roles of intracellular glutathione in antineoplastic chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1347-1354.
40. Rybak L.P., Ravi R., Somani S.M. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fund. Appl. Toxicol. 26:1995;293-300.
41. Salvi R.J., Shulman A., Stracher A., Ding D.L., Wang J. Protecting the ear from acoustic trauma. Int. Tinnitus J. 4:1998;11-15.
42. Schindler R.A., Gladstone H.B., Scott N., Hradek G.T., Williams H., Shah S.B. Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors. Am. J. Otol. 16:1995;304-309.
43. Schweitzer V., Rarey K., Dolon D., Abrams G., Litterst C., Sheridan C. Ototoxicity of cisplatin versus platinum analogues CBDCA (JM-8) and CHIP (JM-9). Otolaryngol. Head Neck Surg. 94:1986;458-470.
44. Singh S.V., Xu B.H., Jani J.P., Emerson E.O., Backes M.G., Rihn C., Scalamogna D., Stemmler N., Specht S., Blanock K., et al. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line. Int. J. Cancer. 6:1995;431-436.
45. Snyder D.L., Salvi R.J. A novel chinchilla restraint device. Lab. Anim. 23:1994;42-44.
46. Takeno S., Harrison R.V., Ibrahim D., Wake M., Mount R.J. Cochlear function after selective inner hair cell degeneration induced by carboplatin. Hear. Res. 75:1994;93-102.
47. Takeno S., Harrison R.V., Mount R.J., Wake M., Harada Y. Induction of selective inner hair cell damage by carboplatin. Scanning Microsc. 8:1994;97-106.
48. Taudy M., Syka J., Popelar J., Ulehlova L. Carboplatin and cisplatin ototoxicity in guinea pigs. Audiology. 31:1992;293-299.
49. Thanislass J., Raveendran M., Devaraj H. Buthionine sulfoximine-induced glutathione depletion. Its effect on antioxidants, lipid peroxidation and calcium homeostasis in the lung. Biochem. Pharmacol. 50:1995;229-234.
50. Tonetti M., Giovine M., Gasparini A., Benatti U., De Flora A. Enhanced formation of reactive species from cis-diammine-(1,1-cyclobutanedicarboxylato)-platinum(II) (carboplatin) in the presence of oxygen free radicals. Biochem. Pharmacol. 46:1993;1377-1383.
51. Trautwein P., Hofstetter P., Wang J., Salvi R., Nostrant A. Selective inner hair cell loss does not alter distortion product otoacoustic emissions. Hear. Res. 96:1996;71-82.
52. Wake M., Takeno S., Ibrahim D., Harrison R. Selective inner hair cell ototoxicity induced by carboplatin. Laryngoscope. 104:1994;488-493.
53. Wake M., Takeno S., Ibrahim D., Harrison R., Mount R. Carboplatin ototoxicity: an animal model. J. Laryngol. Otol. 107:1993;585-589.
54. Walker E.M.J., Gale G.R. Methods of reduction of cisplatin nephrotoxicity. Ann. Clin. Lab. Sci. 11:1981;397-410.
55. Weiss R.B., Christian M.C. New cisplatin analogues in development. A review. Drugs. 46:1993;360-377.